Skip to main content
. Author manuscript; available in PMC: 2020 Sep 28.
Published in final edited form as: Gynecol Oncol. 2015 Aug 1;139(2):261–267. doi: 10.1016/j.ygyno.2015.07.108

Table 6.

Complex hyperplasia with atypia and prevalence of concurrent endometrial cancer.

CAH (−) in biopsy
CAH (+) in biopsy
No. Concurrent cancer (%) P-value No. Concurrent cancer (%) P-value
Total 82 10 (12.2%) 129 33 (25.6%)
Any risk factora 0.078 0.014
 None 5 0 8 1 (12.5%)
 1 risk factor 49 3 (6.1%) 62 9 (14.5%)
 2 risk factors 23 6 (26.1%) 48 18 (29.0%)
 3 risk factors 5 1 (20%) 11 5 (45.5%)
Combination patterns 0.37 0.049
 Age alone 34 2 (5.9%) 39 8 (25.8%)
 BMI alone 12 1 (8.3%) 20 1 (5%)
 DM alone 3 0 3 0
 Age + BMI 13 4 (30.8%) 28 9 (32.1%)
 Age + DM 5 1 (20%) 14 6 (42.9%)
 BMI + DM 5 1 (20%) 6 3 (50%)
 Age + BMI + DM 5 1 (20%) 11 5 (45.5%)

Number (%) is shown. Chi-square test for p-values. Significant p-values are emboldened. Abbreviations: No., number; Age, age ≥ 40; BMI, body mass index ≥ 35 kg/m2; CAH, complex hyperplasia with atypia: and DM, diabetes mellitus.

a

Risk factor included: age ≥ 40, BMI ≥ 35 kg/m2, and diabetes mellitus.